Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuko Harada

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Genes, Chromosomes & Cancer|January 27, 2017
Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomasNatini Jinawath, Meng-Shin Shiao, Alexis Norris, et al.
Acta Cytologica|July 26, 2023
PD-L1 (22C3) Expression Correlates with Clinical and Molecular Features of Lung Adenocarcinomas in Cytological SamplesSarah A Anderson, Djamel Harbi, Diana Oramas Mogrovejo, et al.
The American Journal of Surgical Pathology|March 3, 2026
Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract: A Multi-Institutional StudyManju Aron, Darshan S Chandrashekar, Eman Adulfatah, et al.
British Journal of Haematology|February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2024
Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK-RAS PathwayJoão Lobo, Sofia Canete-Portillo, Maria Del Carmen Rodriguez Pena, et al.
American Journal of Clinical Pathology|June 12, 2020
Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal CancerGregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, et al.
Annals of Clinical and Laboratory Science|July 17, 2019
Abstracts of Presentations at the Association of Clinical Scientists 139<sup>th</sup> Meeting Hershey, PA, May 15-18, 2019Keri Donaldson, Jeanine M Buchanich, Patricia Sue Grigson, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
JAMA Oncology|July 24, 2020
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial, Douglas Yee, Angela M DeMichele, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Genes, Chromosomes & Cancer|January 27, 2017
Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomasNatini Jinawath, Meng-Shin Shiao, Alexis Norris, et al.
Acta Cytologica|July 26, 2023
PD-L1 (22C3) Expression Correlates with Clinical and Molecular Features of Lung Adenocarcinomas in Cytological SamplesSarah A Anderson, Djamel Harbi, Diana Oramas Mogrovejo, et al.
The American Journal of Surgical Pathology|March 3, 2026
Clinical and Molecular Characterization of Clear Cell Adenocarcinoma of the Urinary Tract: A Multi-Institutional StudyManju Aron, Darshan S Chandrashekar, Eman Adulfatah, et al.
British Journal of Haematology|February 18, 2026
Systemic Xanthogranuloma or Erdheim-Chester disease: A systematic review re-examining the classification challengeVyshnavi Rallapalle, Sailesh I S Kumar, Brinda Shukla, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 13, 2024
Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK-RAS PathwayJoão Lobo, Sofia Canete-Portillo, Maria Del Carmen Rodriguez Pena, et al.
American Journal of Clinical Pathology|June 12, 2020
Comparison of Tissue Molecular Biomarker Testing Turnaround Times and Concordance Between Standard of Care and the Biocartis Idylla Platform in Patients With Colorectal CancerGregory J Tsongalis, M Rabie Al Turkmani, Michael Suriawinata, et al.
Annals of Clinical and Laboratory Science|July 17, 2019
Abstracts of Presentations at the Association of Clinical Scientists 139<sup>th</sup> Meeting Hershey, PA, May 15-18, 2019Keri Donaldson, Jeanine M Buchanich, Patricia Sue Grigson, et al.
JACC. Cardiovascular Interventions|November 6, 2017
Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionLarisa H Cavallari, Craig R Lee, Amber L Beitelshees, et al.
JAMA Oncology|July 24, 2020
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial, Douglas Yee, Angela M DeMichele, et al.
Pageof 9